International cooperation to address and counter the world drug problem A/RES/74/178 resolutions adopted by the Commission on Narcotic Drugs and the outcome document of the thirtieth special session of the General Assembly; 100. Expresses concern regarding the overall financial situation of the United Nations Office on Drugs and Crime, emphasizes the need to provide the Office with adequate, predictable and stable resources and to ensure their cost -effective utilization, and requests the Secretary-General to continue to report, within existing reporting obligations, on the financial situation of the Office and to continue to ensure that the Office has sufficient resources to carry out its mandates fully and effectively; 101. Encourages Member States and the United Nations Office on Drugs and Crime to continue to address the above-mentioned issues within the mandate of the standing open-ended intergovernmental working group on improving the governance and financial situation of the Office in order for the Office to fulfil its mand ate effectively, efficiently and with the appropriate resources; 102. Encourages the Commission on Narcotic Drugs, as the principal policymaking organ of the United Nations on matters of international drug control and as the governing body of the drug programme of the United Nations Office on Drugs and Crime, and the International Narcotics Control Board to continue to strengthen their work on the control of precursors and other chemicals used in the illicit manufacture of narcotic drugs and psychotropic s ubstances; 103. Calls upon Member States to strengthen national and international action to address the emerging challenge of new psychoactive substances, including their adverse health consequences, and the evolving threat of amphetamine -type stimulants, including methamphetamine, underscores the importance of enhancing information-sharing and early warning networks, developing appropriate national legislative, prevention and treatment models and supporting scientific evidence -based review and scheduling of the most prevalent, persistent and harmful substances, and notes the importance of preventing the diversion and misuse of pharmaceuticals containing narcotic drugs and psychotropic substances and precursors, while ensuring their availability for legitimate purposes; 104. Urges States that have not done so to consider ratifying or acceding to, and States parties to implement, as a matter of priority, all the provisions of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol, 6 the Convention on Psychotropic Substances of 1971, 7 the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988, the United Nations Convention against Transnational Organized Crime and the Protocols thereto 23 and the United Nations Convention against Corruption; 24 105. Requests the United Nations Office on Drugs and Crime to continue to provide, in close collaboration with the International Narcotics Control Board, as appropriate, adequate support and technical assistance to Governments in all regions so as to enable them to implement and fully meet their obligations under conventions and give adequate follow-up to subsequent resolutions of the Commission on Narcotic Drugs, the Economic and Social Council and the General Assembly, including for the strengthening of regulatory authorities and controls, provision of information and fulfilment of reporting requirements, and urges donors to contribute to the Office for those purposes; 106. Takes note of the resolutions adopted by the Commission on Narcotic Drugs at its sixty-second session 2 and of the World Drug Report 2019; __________________ 23 24 20/23 United Nations, Treaty Series, vols. 2225, 2237, 2241 and 2326, No. 39574. Ibid., vol. 2349, No. 42146. 19-22335

Select target paragraph3

Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents